Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7497 p447
12 April 2008


Society summary


Staged retention fee payments may be available from 2009

The Council has moved a step closer towards the introduction of retention fee payments by instalment. At the April Council meeting, draft rules were approved which could see staged payments being introduced in time for the collection of retention fees for 2009.

The Council heard that the draft rules it was being asked to approve allowed greater flexibility than the approach originally taken by the Society, enabling it to vary the frequency of staged fee payments and offer the service to non-practising members as well as practising members without the need to make new rules.

There was also a change proposed which would allow the Society to offer staged payments to pharmacy technicians once the statutory regulation of such technicians came into force.

The Society had also received advice from the Department of Health that it may not be necessary to undertake a new consultation exercise with members to make the proposed amendments to the Royal Pharmaceutical Society of Great Britain (Registration) Rules 2007.

The reason for that was because the fees consultation exercise carried out by the Society in summer 2007 and reviewed by the Council in November 2007 addressed the issue of staged payments sufficiently — and elicited general consent for their introduction — to allow the Council properly to reach a decision on the issue.

JONATHAN BUISSON agreed in general with the proposal but spoke against the fee collection schedule beginning in January. The members made it clear they did not want January, he said. That had come across loud and clear during the consultation. “And I note that the development costs of circa £8,000 are in the region of 15p per member. Are we a members-backed organisation that listens, or not,” he asked.

The TREASURER replied that the Society was indeed a member-focused organisation that listens. He explained: “Initially it was suggested that we would have to do an in-advance payment, and the initial payment would be asked for at the end of November. Members said that they did not want a prepayment, but we had to have some payment at the beginning of the year to meet some legislative requirements.

“So we have listened and we have set the first payment at the latest possible date to allow this to go forward. So yes … we should be a listening organisation, and hopefully we are demonstrating that.”

Back to Top


©The Pharmaceutical Journal